(NNIT) Nnit AS - Ratings and Ratios
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060580512
NNIT: IT Solutions, Data, AI, Cybersecurity, Software, Cloud, Applications
NNIT A/S is a leading provider of IT solutions and services, specializing in the life sciences, public, and private sectors across Denmark, Europe, the United States, and Asia. The company delivers a comprehensive suite of solutions, including data and AI, cybersecurity, Microsoft and SAP services, as well as specialized offerings such as NNIT Veeva powerhouse, clinical, drug safety, regulatory affairs, laboratory, manufacturing, and supply chain management. Additional services include quality assurance, compliance, migration powerhouse, custom application development, and cloud solutions. Founded in 1994, NNIT A/S is headquartered in Copenhagen, Denmark, and operates with a strong focus on innovation and customer-centric solutions.
From a technical perspective, NNIT A/S (Ticker: NNIT) is currently trading at 72.50 DKK, with a 20-day moving average of 67.30 and a 50-day moving average of 73.12. The 200-day moving average stands at 95.53, indicating a potential downtrend in the longer term. The Average True Range (ATR) of 2.66 suggests moderate volatility. The stocks average 20-day volume is 8,152 shares.
Fundamentally, NNIT A/S has a market capitalization of 1,690.28M DKK, with a price-to-earnings (P/E) ratio of 2263.33, reflecting high valuation relative to earnings. The forward P/E is not available. The price-to-book (P/B) ratio of 1.94 indicates that the stock is trading at a modest premium to its book value. The price-to-sales (P/S) ratio of 0.91 suggests the stock may be undervalued relative to its revenue generation. Return on equity (RoE) is 2.36, indicating modest profitability.
3-Month Forecast: Based on technical and fundamental data, NNIT A/S is expected to experience short-term volatility. The stocks recent uptrend, as indicated by the rising SMA 20, may continue if momentum persists. However, the gap between the SMA 50 and SMA 200 suggests potential resistance at higher levels.Fundamentally, the high P/E ratio may lead to profit-taking, while the low P/S ratio could attract value investors. Overall, the stock is likely to trade in a range-bound manner, with support near 67.30 and resistance near 73.12.
Additional Sources for NNIT Stock
NNIT Stock Overview
Market Cap in USD | 256m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
NNIT Stock Ratings
Growth Rating | -47.3 |
Fundamental | -12.4 |
Dividend Rating | 1.0 |
Rel. Strength | -39.9 |
Analysts | - |
Fair Price Momentum | 60.07 DKK |
Fair Price DCF | - |
NNIT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 42.1% |
NNIT Growth Ratios
Growth Correlation 3m | -89.9% |
Growth Correlation 12m | -82.8% |
Growth Correlation 5y | -46% |
CAGR 5y | -7.08% |
CAGR/Max DD 5y | -0.11 |
Sharpe Ratio 12m | -1.79 |
Alpha | -42.50 |
Beta | 0.766 |
Volatility | 44.71% |
Current Volume | 22.3k |
Average Volume 20d | 7.7k |
As of May 05, 2025, the stock is trading at DKK 73.90 with a total of 22,343 shares traded.
Over the past week, the price has changed by +9.97%, over one month by +17.86%, over three months by -19.32% and over the past year by -33.54%.
Neither. Based on ValueRay Fundamental Analyses, Nnit AS is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NNIT as of May 2025 is 60.07. This means that NNIT is currently overvalued and has a potential downside of -18.71%.
Nnit AS has no consensus analysts rating.
According to ValueRays Forecast Model, NNIT Nnit AS will be worth about 67.9 in May 2026. The stock is currently trading at 73.90. This means that the stock has a potential downside of -8.15%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 95 | 28.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 67.9 | -8.1% |